Milestone Scientific Inc. (MLSS) Earns Buy Rating from Maxim Group
Milestone Scientific Inc. (AMEX:MLSS)‘s stock had its “buy” rating restated by analysts at Maxim Group in a research report issued to clients and investors on Tuesday, StockTargetPrices.com reports. They currently have a $4.00 price target on the medical instruments supplier’s stock. Maxim Group’s price objective suggests a potential upside of 158.06% from the stock’s previous close.
Milestone Scientific (AMEX MLSS) traded up 1.64% during trading on Tuesday, reaching $1.55. The company’s stock had a trading volume of 50,321 shares. Milestone Scientific has a 52 week low of $1.10 and a 52 week high of $3.04. The firm has a 50-day moving average price of $1.40 and a 200-day moving average price of $1.42. The firm’s market capitalization is $95.27 million.
About Milestone Scientific
Milestone Scientific Inc (Milestone) is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets. The Company uses its CompuFlo technology for the delivery of medicaments. The CompuFlo pressure or force Computer-Controlled Local Anesthetic Delivery (C-CLAD) technology is a medical technology for the delivery of drugs, anesthetics and other medicaments into various tissue types.
Receive News & Ratings for Milestone Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific Inc. and related companies with MarketBeat.com's FREE daily email newsletter.